Insider · CIK 0001834835

Kieffer Tara Lynn

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001834835

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+1,575 sh	—	—	32,195
2026-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+4,987 sh	—	—	37,182
2026-02-12	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−3,257 sh	$14.25	−$46.4K	33,925
2025-12-05	ENTAENANTA PHARMACEUTICALS INCS Sale	Chief Product Strategy Officer	SSale	−2,106 sh	$14.23	−$30K	30,620
2025-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−753 sh	$14.12	−$10.6K	32,726
2025-11-25	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+100K sh	—	—	100,000
2025-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+7,500 sh	—	—	36,805
2025-02-12	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−3,326 sh	$5.59	−$18.6K	33,479
2024-12-06	ENTAENANTA PHARMACEUTICALS INCS Sale	Chief Product Strategy Officer	SSale	−2,283 sh	$8.06	−$18.4K	29,305
2024-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−753 sh	$8.60	−$6,475.8	31,588
2024-11-27	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+81K sh	—	—	81,000
2024-06-17	ENTAENANTA PHARMACEUTICALS INCS Sale	Chief Product Strategy Officer	SSale	−7,266 sh	$12.33	−$89.6K	32,341
2024-02-12	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+3,320 sh	—	—	40,580
2024-02-12	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−973 sh	$12.41	−$12.1K	39,607
2023-12-05	ENTAENANTA PHARMACEUTICALS INCS Sale	Chief Product Strategy Officer	SSale	−2,125 sh	$9.63	−$20.5K	37,260
2023-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−753 sh	$9.49	−$7,145.97	39,385
2023-11-22	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+83K sh	—	—	83,000
2023-02-13	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+9,250 sh	—	—	35,116
2023-02-13	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+11.7K sh	—	—	46,863
2023-02-13	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−6,725 sh	$52.77	−$355K	40,138
2022-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−498 sh	$44.33	−$22.1K	25,866
2022-11-23	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+18.5K sh	—	—	26,364
2022-11-23	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+40K sh	—	—	40,000
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+327 sh	—	—	7,127
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+1,289 sh	—	—	8,416
2022-02-14	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Chief Product Strategy Officer	FTax Payment	−552 sh	$62.49	−$34.5K	7,864
2021-11-19	ENTAENANTA PHARMACEUTICALS INCA Award	Chief Product Strategy Officer	AAward	+6,800 sh	—	—	6,800
2021-11-19	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+28.4K sh	—	—	28,400
2020-12-07	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Chief Product Strategy Officer	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
Feb 134
Kieffer Tara Lynn0002064832-26-000012
SEC(opens sec.gov)
Dec 54
Kieffer Tara Lynn0002064832-25-000061
SEC(opens sec.gov)
Dec 34
Kieffer Tara Lynn0002064832-25-000046
SEC(opens sec.gov)
Nov 264
Kieffer Tara Lynn0002064832-25-000032
SEC(opens sec.gov)
Feb 144
Kieffer Tara Lynn0001062993-25-002563
SEC(opens sec.gov)
Dec 104
Kieffer Tara Lynn0001062993-24-020386
SEC(opens sec.gov)
Dec 34
Kieffer Tara Lynn0001062993-24-019987
SEC(opens sec.gov)
Nov 274
Kieffer Tara Lynn0001062993-24-019772
SEC(opens sec.gov)
Jun 174
Kieffer Tara Lynn0001062993-24-012734
SEC(opens sec.gov)
Feb 144
Kieffer Tara Lynn0001062993-24-003235
SEC(opens sec.gov)
Dec 64
Kieffer Tara Lynn0001062993-23-022055
SEC(opens sec.gov)
Dec 54
Kieffer Tara Lynn0001062993-23-021989
SEC(opens sec.gov)
Nov 224
Kieffer Tara Lynn0001062993-23-021384
SEC(opens sec.gov)
Feb 154
Kieffer Tara Lynn0001062993-23-003719
SEC(opens sec.gov)

Companies

ENANTA PHARMACEUTICALS INCChief Product Strategy OfficerENTA

Address

C/O ENANTA PHARMACEUTICALS, INC. 4 KINGSBURY AVENUE

WATERTOWN, MA, 02472